EUVIMED · CrossrefZeitschrift
JAMA Dermatology
ISSN 2168-6068 · American Medical Association (AMA)
Neueste Artikel
Rethinking Low Disease Activity in Atopic Dermatitis—Reply
Clinical Characteristics, Etiologic Associations, and Treatment Outcomes of Pernio
Rethinking Low Disease Activity in Atopic Dermatitis
Autoinflammatory Syndromes—Recognizing Autoinflammatory Diseases in Dermatology
Tuberculosis Verrucosa Cutis With Chronic Lymphedema
Diffuse Lip Swelling and Oral Nodules in an Adolescent
Prevalence of Chronic Hand Eczema in Adults
Incidence of Cancer in Morphea and Systemic Sclerosis
Errors in Figure 2 and the Methods
Efficacy and Safety of Brepocitinib in Cutaneous Sarcoidosis
Intravascular Large B-Cell Lymphoma
Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis
Ultrasonography and International Perspectives on Imaging Consensus for Cutaneous Squamous Cell Carcinoma—Reply
Ultrasonography and International Perspectives on Imaging Consensus for Cutaneous Squamous Cell Carcinoma
End-of-Dose Effect as a Guide for Biologic Optimization in Hidradenitis Suppurativa
Global Disparities in Access to Dermatological Care
Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis
BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus
Best Practices for Managing Pseudofolliculitis Barbae
Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence
Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma
Is Postinflammatory Hyperpigmentation Truly “Post” in People With Darker Skin Tones?
The Absent Original in Smartphone Photography—Reply
The Absent Original in Smartphone Photography
Global Skin Cancer Burden From 1990 to 2023 and Projection to 2050
Clinical Characteristics and Treatment Patterns in Patients With Vitiligo
Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic Settings
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity
EUVIMED